查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683254

全球即時傳染病檢測市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測 2025 至 2033 年

Global Point of Care Infectious Disease Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2個工作天內

價格

全球即時傳染病檢測市場規模預計將從 2024 年的 175.5 億美元成長到 2033 年的 271.5 億美元，在 2026 年至 2033 年的預測期內呈現 4.97% 的強勁年複合成長率(CAGR)。

面對日益增多的傳染病，對快速且準確的診斷解決方案的需求不斷增加，推動全球即時診斷（POC）傳染病檢測市場有望大幅成長。 COVID-19 疫情凸顯了及時檢測對於控制疫情和有效管理公共衛生的迫切必要性。 POC 測試的優點在於可以在幾分鐘內提供結果，使醫療保健提供者能夠快速做出明智的決定並進行適當的治療。隨著對傳染病早期發現和預防的關注度不斷提高，POC 檢測解決方案的採用預計將加速，從而促進這一重要市場的創新和投資。

此外，技術的進步將改變 POC 傳染病檢測格局。分子診斷、微流體和生物感測器的整合提高了測試的敏感性和特異性，可以檢測多種病原體，包括細菌、病毒和寄生蟲。此外，可以在診所到偏遠地區等各種環境中操作的方便用戶使用型設備的開發正在擴大檢測管道。隨著醫療保健系統越來越重視分散式測試方法，對能夠即時提供準確結果的創新 POC 解決方案的需求將持續上升。

此外，對個人化醫療的日益重視和對全球健康計劃的日益關注預計將塑造POC傳染病檢測市場的未來。隨著醫療保健提供者尋求根據個別患者的需求制定治療方案，對能夠為臨床決策提供參考的快速診斷工具的需求變得至關重要。 POC 測試符合這一趨勢，使醫療保健專業人員能夠快速評估患者的狀況並相應地調整治療計劃。此外，旨在對抗傳染病的全球衛生計畫（特別是在資源匱乏的環境中）正在推動對可在不同環境中部署的 POC 測試技術的投資。診斷製造商、醫療保健組織和公共衛生機構之間的協作努力對於推動這些解決方案至關重要，確保 POC 傳染病檢測市場保持敏捷並能應對新出現的健康挑戰。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特銷售主張 (USP) 產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：即時診斷傳染病檢測產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 依疾病進行市場吸引力分析
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球即時傳染病檢測市場分析：依疾病分類

  • 疾病概覽
  • 歷史和預測數據
  • 疾病分析
  • 愛滋病毒陽性檢測結果
  • 艱難梭菌 POC
  • 乙肝病毒陽性檢測結果
  • 肺炎或鏈球菌相關感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV 陽性結果
  • 流感/流感 POC
  • 丙型肝炎病毒
  • 抗甲氧西林金黃色葡萄球菌
  • 結核病和抗藥性結核病 POC
  • HSV（單純皰疹病毒） POC
  • 其他傳染病 POC

第 6 章：全球即時傳染病檢測市場分析：依最終用途

  • 按最終用途概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 診所
  • 家
  • 輔助生活醫療設施
  • 實驗室
  • 其他

第 7 章：全球即時診斷傳染病檢測市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東非洲分部銷售分析
    • 中東非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 8 章：即時診斷傳染病檢測公司的競爭格局

  • 傳染病即時檢測市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第9章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Alere
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Siemens Healthineers
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Chembio Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Trinity Biotech
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cardinal Health
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Labs Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioMéRieux SA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sight Diagnostics Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gene POC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Trivitron Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • OJ-Bio Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Ortho-Clinical Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11212341

Global Point of Care Infectious Disease Testing Market size is anticipated to grow from USD 17.55 Billion in 2024 to USD 27.15 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The global point of care (POC) infectious disease testing market is poised for significant growth, driven by the increasing demand for rapid and accurate diagnostic solutions in the face of rising infectious diseases. The COVID-19 pandemic has underscored the critical need for timely testing to control outbreaks and manage public health effectively. POC testing offers the advantage of delivering results within minutes, enabling healthcare providers to make informed decisions quickly and initiate appropriate treatment. As the focus on early detection and prevention of infectious diseases intensifies, the adoption of POC testing solutions is expected to accelerate, fostering innovation and investment in this vital market.

Moreover, advancements in technology are set to transform the POC infectious disease testing landscape. The integration of molecular diagnostics, microfluidics, and biosensors is enhancing the sensitivity and specificity of tests, allowing for the detection of a wide range of pathogens, including bacteria, viruses, and parasites. Additionally, the development of user-friendly devices that can be operated in various settings, from clinics to remote locations, is expanding access to testing. As healthcare systems increasingly prioritize decentralized testing approaches, the demand for innovative POC solutions that can deliver accurate results in real-time will continue to rise.

In addition, the growing emphasis on personalized medicine and the increasing focus on global health initiatives are expected to shape the future of the POC infectious disease testing market . As healthcare providers seek to tailor treatments to individual patient needs, the demand for rapid diagnostic tools that can inform clinical decisions is becoming paramount. POC testing aligns with this trend by enabling healthcare professionals to quickly assess a patient's condition and adjust treatment plans accordingly. Furthermore, global health initiatives aimed at combating infectious diseases, particularly in low-resource settings, are driving investments in POC testing technologies that can be deployed in diverse environments. Collaborative efforts between diagnostic manufacturers, healthcare organizations, and public health agencies will be essential in advancing these solutions, ensuring that the POC infectious disease testing market remains agile and responsive to emerging health challenges.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Lateral Flow Immunoassay
  • Agglutination Test
  • Flow-through test/Immunoconcentration Assay
  • Molecular Diagnostics
  • Others

By Disease

  • HIV POC
  • Clostridium Difficile POC
  • HBV POC
  • Pneumonia Or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB & Drug-resistant TB POC
  • HSV POC
  • COVID-19
  • Others

By End Use

  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratory
  • COMPANIES PROFILED
  • Abbott
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Becton
  • Dickinson & Company
  • Chembio Diagnostics Inc.
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics Incorporated
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Sight Diagnostics Ltd.
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio Ltd.
  • Ortho-Clinical Diagnostics
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. HIV POC Historic and Forecast Sales By Regions
  • 5.5. Clostridium difficile POC Historic and Forecast Sales By Regions
  • 5.6. HBV POC Historic and Forecast Sales By Regions
  • 5.7. Pneumonia or Streptococcus associated infections Historic and Forecast Sales By Regions
  • 5.8. Respiratory syncytial virus (RSV) POC Historic and Forecast Sales By Regions
  • 5.9. HPV POC Historic and Forecast Sales By Regions
  • 5.10. Influenza/Flu POC Historic and Forecast Sales By Regions
  • 5.11. HCV POC Historic and Forecast Sales By Regions
  • 5.12. MRSA POC Historic and Forecast Sales By Regions
  • 5.13. TB and drug-resistant TB POC Historic and Forecast Sales By Regions
  • 5.14. HSV (Herpes Simplex Virus) POC Historic and Forecast Sales By Regions
  • 5.15. Other infectious disease POC Historic and Forecast Sales By Regions

6. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End-Use
  • 6.4. Hospitals Historic and Forecast Sales By Regions
  • 6.5. Clinics Historic and Forecast Sales By Regions
  • 6.6. Home Historic and Forecast Sales By Regions
  • 6.7. Assisted Living Healthcare Facilities Historic and Forecast Sales By Regions
  • 6.8. Laboratories Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East Africa By Segment Sales Analysis
    • 7.7.3 Middle East Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE POINT OF CARE INFECTIOUS DISEASE TESTING COMPANIES

  • 8.1. Point of Care Infectious Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alere
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Thermo Fisher Scientific Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Siemens Healthineers
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. BD Company
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Chembio Diagnostics Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Trinity Biotech
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Cardinal Health
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Quest Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Bio-Rad Labs Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. BioMéRieux SA
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Sight Diagnostics Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Gene POC
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Trivitron Healthcare
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. OJ-Bio Ltd.
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Ortho-Clinical Diagnostics
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Point of Care Infectious Disease Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Point of Care Infectious Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Point of Care Infectious Disease Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.